Table 2

Classification performance of the five-category pathological classification model in four cohorts

CohortHistologic typePrediction performance
AUC (95% CI)SensitivitySpecificityPPVNPVAccuracy
Training
(n = 600)
IPMN0.95 (0.93–0.96)0.810.910.770.930.88
MCN0.85 (0.80–0.88)0.480.910.540.890.83
SCN0.90 (0.87–0.93)0.730.860.710.860.81
NET0.97 (0.95–0.98)0.780.970.740.970.94
SPN0.99 (0.97–0.99)0.850.990.900.980.97
Mean0.92 (0.90–0.94)0.730.930.730.930.89
Internal validation
(n = 258)
IPMN0.95 (0.93–0.97)0.790.920.790.920.88
MCN0.87 (0.81–0.94)0.610.920.610.920.86
SCN0.90 (0.86–0.94)0.750.860.720.880.83
NET0.96 (0.88–0.99)0.760.980.810.970.95
SPN0.98 (0.95–1.00)0.820.980.850.980.97
Mean0.93 (0.90–0.95)0.750.930.760.930.90
Temporal validation
(n = 244)
IPMN0.96 (0.93–0.98)0.900.900.800.950.90
MCN0.91 (0.87–0.95)0.540.900.460.930.85
SCN0.90 (0.87–0.94)0.620.910.750.850.82
NET0.87 (0.78–0.95)0.500.940.390.960.91
SPN0.98 (0.95–0.99)0.730.980.880.950.94
Mean0.93 (0.91–0.95)0.660.930.660.930.88
Prospective validation
(n = 58)
IPMN—1.000.850.761.000.90
MCN—0.860.980.860.980.97
SCN—0.650.970.930.840.86
NET—1.001.001.001.001.00
SPN—1.001.001.001.001.00
Mean—0.900.960.910.960.86

AUC, area under the receiver operating characteristic curve; CI, confidence interval; IPMN, intraductal papillary mucinous neoplasm; MCN, mucinous cystic neoplasm; SCN, serous cystic neoplasm; SPN, solid pseudopapillary neoplasm; NET, neuroendocrine tumor; NPV, negative predictive value; PPV, positive predictive value.